ChoiceSpine has received 510(k) clearance from the US Food and Drug Administration (FDA) to market titanium lumbar interbody fusion devices.
A ChoiceSpine press release states that the company now plans to offer titanium interbody devices for traditional PLIF (posterior lumbar interbody fusion) and TLIF (transforaminal lumbar interbody fusion) approaches, as well as the new VLIF (visualised lateral interbody fusion) approach.
